498 related articles for article (PubMed ID: 27975250)
21. Post-translational modifications of tau protein.
Pevalova M; Filipcik P; Novak M; Avila J; Iqbal K
Bratisl Lek Listy; 2006; 107(9-10):346-53. PubMed ID: 17262986
[TBL] [Abstract][Full Text] [Related]
22. Post-translational modifications of tau protein in Alzheimer's disease.
Gong CX; Liu F; Grundke-Iqbal I; Iqbal K
J Neural Transm (Vienna); 2005 Jun; 112(6):813-38. PubMed ID: 15517432
[TBL] [Abstract][Full Text] [Related]
23. Post-translational modifications of tau protein: implications for Alzheimer's disease.
Martin L; Latypova X; Terro F
Neurochem Int; 2011 Mar; 58(4):458-71. PubMed ID: 21215781
[TBL] [Abstract][Full Text] [Related]
24. Emerging mass spectrometry-based technologies for analyses of chromatin changes: analysis of histones and histone modifications.
Shah B; Kozlowski RL; Han J; Borchers CH
Methods Mol Biol; 2011; 773():259-303. PubMed ID: 21898261
[TBL] [Abstract][Full Text] [Related]
25. Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology.
Kalyaanamoorthy S; Opare SK; Xu X; Ganesan A; Rao PPN
Curr Alzheimer Res; 2024 Apr; ():. PubMed ID: 38623984
[TBL] [Abstract][Full Text] [Related]
26. Uncommon posttranslational modifications in proteomics: ADP-ribosylation, tyrosine nitration, and tyrosine sulfation.
Bashyal A; Brodbelt JS
Mass Spectrom Rev; 2024; 43(2):289-326. PubMed ID: 36165040
[TBL] [Abstract][Full Text] [Related]
27. The Involvement of Post-Translational Modifications in Alzheimer's Disease.
Marcelli S; Corbo M; Iannuzzi F; Negri L; Blandini F; Nistico R; Feligioni M
Curr Alzheimer Res; 2018 Feb; 15(4):313-335. PubMed ID: 28474569
[TBL] [Abstract][Full Text] [Related]
28. The Study of Posttranslational Modifications of Tau Protein by Nuclear Magnetic Resonance Spectroscopy: Phosphorylation of Tau Protein by ERK2 Recombinant Kinase and Rat Brain Extract, and Acetylation by Recombinant Creb-Binding Protein.
Qi H; Despres C; Prabakaran S; Cantrelle FX; Chambraud B; Gunawardena J; Lippens G; Smet-Nocca C; Landrieu I
Methods Mol Biol; 2017; 1523():179-213. PubMed ID: 27975251
[TBL] [Abstract][Full Text] [Related]
29. Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in Neurodegeneration.
Zafar S; Fatima SI; Schmitz M; Zerr I
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254718
[TBL] [Abstract][Full Text] [Related]
30. Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains.
Arakhamia T; Lee CE; Carlomagno Y; Duong DM; Kundinger SR; Wang K; Williams D; DeTure M; Dickson DW; Cook CN; Seyfried NT; Petrucelli L; Fitzpatrick AWP
Cell; 2020 Feb; 180(4):633-644.e12. PubMed ID: 32032505
[TBL] [Abstract][Full Text] [Related]
31. Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation.
Alquezar C; Arya S; Kao AW
Front Neurol; 2020; 11():595532. PubMed ID: 33488497
[TBL] [Abstract][Full Text] [Related]
32. Quantitative profiling of posttranslational modifications of pathological tau via sarkosyl fractionation and mass spectrometry.
Wenger K; Viode A; Kumar M; Steen H; Steen JA
Nat Protoc; 2024 Apr; 19(4):1235-1251. PubMed ID: 38291250
[TBL] [Abstract][Full Text] [Related]
33. Conserved Lysine Acetylation within the Microtubule-Binding Domain Regulates MAP2/Tau Family Members.
Hwang AW; Trzeciakiewicz H; Friedmann D; Yuan CX; Marmorstein R; Lee VM; Cohen TJ
PLoS One; 2016; 11(12):e0168913. PubMed ID: 28002468
[TBL] [Abstract][Full Text] [Related]
34. The acetylation of tau inhibits its function and promotes pathological tau aggregation.
Cohen TJ; Guo JL; Hurtado DE; Kwong LK; Mills IP; Trojanowski JQ; Lee VM
Nat Commun; 2011; 2():252. PubMed ID: 21427723
[TBL] [Abstract][Full Text] [Related]
35. Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice.
Morris M; Knudsen GM; Maeda S; Trinidad JC; Ioanoviciu A; Burlingame AL; Mucke L
Nat Neurosci; 2015 Aug; 18(8):1183-9. PubMed ID: 26192747
[TBL] [Abstract][Full Text] [Related]
36. The Role of Post-Translational Modifications on the Structure and Function of Tau Protein.
Ye H; Han Y; Li P; Su Z; Huang Y
J Mol Neurosci; 2022 Aug; 72(8):1557-1571. PubMed ID: 35325356
[TBL] [Abstract][Full Text] [Related]
37. Site-specific nitration and oxidative dityrosine bridging of the tau protein by peroxynitrite: implications for Alzheimer's disease.
Reynolds MR; Berry RW; Binder LI
Biochemistry; 2005 Feb; 44(5):1690-700. PubMed ID: 15683253
[TBL] [Abstract][Full Text] [Related]
38. Quantification of Methylation and Phosphorylation Stoichiometry.
Ayoub CA; Moore KI; Kuret J
Methods Mol Biol; 2024; 2754():221-235. PubMed ID: 38512670
[TBL] [Abstract][Full Text] [Related]
39. Quantitative mass spectrometry of posttranslational modifications: keys to confidence.
Hennrich ML; Gavin AC
Sci Signal; 2015 Apr; 8(371):re5. PubMed ID: 25852188
[TBL] [Abstract][Full Text] [Related]
40. Proteomics in Influenza Research: The Emerging Role of Posttranslational Modifications.
Zhang J; Peng Q; Zhao W; Sun W; Yang J; Liu N
J Proteome Res; 2021 Jan; 20(1):110-121. PubMed ID: 33348980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
